Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,722 | 189 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $569.77 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $477.10 | 23 | $0 (2024) |
| ABBVIE INC. | $393.68 | 17 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $362.27 | 17 | $0 (2023) |
| Alkermes, Inc. | $320.65 | 17 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $288.61 | 13 | $0 (2024) |
| ITI, Inc. | $277.36 | 15 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $262.83 | 12 | $0 (2022) |
| Lundbeck LLC | $165.50 | 9 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $132.17 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $331.31 | 17 | Neurocrine Biosciences, Inc. ($87.29) |
| 2023 | $776.63 | 42 | Teva Pharmaceuticals USA, Inc. ($177.75) |
| 2022 | $1,649 | 78 | ABBVIE INC. ($353.82) |
| 2021 | $965.86 | 52 | Takeda Pharmaceuticals U.S.A., Inc. ($151.13) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Neuropsychiatry | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Central Nervous System | ||||||
| 08/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Neuropsychiatry | ||||||
| 05/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Neuropsychiatry | ||||||
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Central Nervous System | ||||||
| 04/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Central Nervous System | ||||||
| 11/07/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.98 | General |
| Category: PSYCHOLOGY | ||||||
| 10/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: Central Nervous System | ||||||
| 10/03/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: INSOMNIA | ||||||
| 09/26/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 149 | 393 | $53,395 | $23,774 |
| 2022 | 2 | 87 | 267 | $31,350 | $14,901 |
| 2021 | 3 | 88 | 272 | $32,950 | $15,710 |
| 2020 | 3 | 74 | 215 | $26,700 | $10,153 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 223 | $31,220 | $15,381 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 98 | $9,800 | $3,873 | 39.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 27 | 27 | $6,750 | $2,780 | 41.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 15 | 45 | $5,625 | $1,740 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 236 | $23,600 | $11,727 | 49.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 30 | 31 | $7,750 | $3,174 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 217 | $21,700 | $11,013 | 50.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 30 | 30 | $7,500 | $3,553 | 47.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 25 | $3,750 | $1,145 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 149 | $14,900 | $6,307 | 42.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 47 | $7,050 | $2,228 | 31.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 19 | 19 | $4,750 | $1,618 | 34.1% |
About George Mcbride, PMHNP-BC
George Mcbride, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Cleveland, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2019. The National Provider Identifier (NPI) number assigned to this provider is 1962061473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, George Mcbride, PMHNP-BC has received a total of $3,722 in payments from pharmaceutical and medical device companies, with $331.31 received in 2024. These payments were reported across 189 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,722).
As a Medicare-enrolled provider, Mcbride has provided services to 398 Medicare beneficiaries, totaling 1,147 services with total Medicare billing of $64,539. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Cleveland, TN
- Active Since 06/08/2019
- Last Updated 06/08/2019
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1962061473
Products in Payments
- VRAYLAR (Drug) $393.68
- AUSTEDO (Drug) $379.77
- TRINTELLIX (Drug) $362.27
- REXULTI (Drug) $352.99
- INGREZZA (Drug) $288.61
- CAPLYTA (Drug) $277.36
- ABILIFY MAINTENA (Drug) $270.93
- LATUDA (Drug) $262.83
- LYBALVI (Drug) $215.52
- Austedo XR (Drug) $161.48
- SPRAVATO (Drug) $112.57
- ARISTADA (Drug) $84.19
- NEUROSTAR TMS THERAPY SYSTEM (Device) $79.93
- QELBREE (Drug) $73.95
- QUVIVIQ (Drug) $67.95
- Qelbree (Drug) $58.22
- FANAPT (Drug) $36.37
- APLENZIN (Drug) $33.81
- HETLIOZ (Drug) $33.81
- Azstarys (Drug) $28.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Cleveland
Lawanda Glass, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $5,787
David Kwon, Np, NP
Psychiatric/Mental Health — Payments: $4,046
Sandra Jones, Cnp, CNP
Psychiatric/Mental Health — Payments: $3,820
Lindsay Conger
Psychiatric/Mental Health — Payments: $2,867
Julie Mcbride, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,834
Mary Louise Tatum, Msn, Np, MSN, NP
Psychiatric/Mental Health — Payments: $2,564